AAAAAA
Results: 1-25/39
Authors:
Djeha, AH
Thomson, TA
Leung, H
Searle, PF
Young, LS
Kerr, DJ
Harris, PA
Mountain, A
Wrighton, CJ
Citation: Ah. Djeha et al., Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: A well-tolerated therapy for established solid tumors, MOL THER, 3(2), 2001, pp. 233-240
Authors:
Chen, MJ
Chung-Faye, GA
Searle, PF
Young, LS
Kerr, DJ
Citation: Mj. Chen et al., Gene therapy for colorectal cancer - Therapeutic potential, BIODRUGS, 15(6), 2001, pp. 357-367
Authors:
Chung-Faye, G
Palmer, D
Anderson, D
Clark, J
Downes, M
Baddeley, J
Hussain, S
Murray, PI
Searle, P
Seymour, L
Harris, PA
Ferry, D
Kerr, DJ
Citation: G. Chung-faye et al., Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: A phase I and pharmacokinetic study of its prodrug, CB1954, CLIN CANC R, 7(9), 2001, pp. 2662-2668
Authors:
Chung-Faye, GA
Chen, MJ
Green, NK
Burton, A
Anderson, D
Mautner, V
Searle, PF
Kerr, DJ
Citation: Ga. Chung-faye et al., In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase, GENE THER, 8(20), 2001, pp. 1547-1554
Authors:
Young, AM
Kerr, DJ
Citation: Am. Young et Dj. Kerr, Home delivery: chemotherapy and pizza? Evidence on safety and acceptability of home chemotherapy is growing, BR MED J, 322(7290), 2001, pp. 809-810
Authors:
Grumett, SA
Archer, VR
Midgley, R
Mulholland, P
Nicum, S
Blewitt, L
Kerr, DJ
Citation: Sa. Grumett et al., The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy, ANN ONCOL, 12(4), 2001, pp. 575-575
Authors:
Hussain, SA
Ferry, DR
El-Gazzaz, G
Mirza, DF
James, ND
McMaster, P
Kerr, DJ
Citation: Sa. Hussain et al., Hepatocellular carcinoma, ANN ONCOL, 12(2), 2001, pp. 161-172
Authors:
Mulholland, PJ
Ferry, DR
Anderson, D
Hussain, SA
Young, AM
Cook, JE
Hodgkin, E
Seymour, LW
Kerr, DJ
Citation: Pj. Mulholland et al., Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin, ANN ONCOL, 12(2), 2001, pp. 245-248
Authors:
Kerr, DJ
Citation: Dj. Kerr, Two cultures or two faces?, ANN ONCOL, 12(1), 2001, pp. 7-8
Authors:
Neoptolemos, JP
Dunn, JA
Stocken, DD
Almond, J
Link, K
Beger, H
Bassi, C
Falconi, M
Pederzoli, P
Dervenis, C
Fernandez-Cruz, L
Lacaine, F
Pap, A
Spooner, D
Kerr, DJ
Friess, H
Buchler, MW
Citation: Jp. Neoptolemos et al., Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial, LANCET, 358(9293), 2001, pp. 1576-1585
Authors:
Kerr, DJ
Citation: Dj. Kerr, A United Kingdom Coordinating Committee on cancer research study of adjuvant chemotherapy for colorectal cancer: Preliminary results, SEMIN ONCOL, 28(1), 2001, pp. 31-34
Authors:
Snow, PB
Kerr, DJ
Brandt, JM
Rodvold, DM
Citation: Pb. Snow et al., Neural network and regression predictions of 5-year survival after colon carcinoma treatment, CANCER, 91(8), 2001, pp. 1673-1678
Authors:
Neoptolemos, JP
Stocken, DD
Dunn, JA
Almond, J
Beger, HG
Pederzoli, P
Bassi, C
Dervenis, C
Fernandez-Cruz, L
Lacaine, F
Buckels, J
Deakin, M
Adab, FA
Sutton, R
Imrie, C
Ihse, I
Tihanyi, T
Olah, A
Pedrazzoli, S
Spooner, D
Kerr, DJ
Friess, H
Buchler, MW
Citation: Jp. Neoptolemos et al., Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial, ANN SURG, 234(6), 2001, pp. 758-768
Authors:
Midgley, RS
Kerr, DJ
Citation: Rs. Midgley et Dj. Kerr, Adjuvant therapy of colorectal cancer, HOSP PRACT, 35(5), 2000, pp. 55-62
Authors:
Chung-Faye, GA
Kerr, DJ
Young, LS
Searle, PF
Citation: Ga. Chung-faye et al., Gene therapy strategies for colon cancer, MOL MED TOD, 6(2), 2000, pp. 82-87
Authors:
Chung-Faye, GA
Kerr, DJ
Citation: Ga. Chung-faye et Dj. Kerr, ABC of colorectal cancer - Innovative treatment for colon cancer, BR MED J, 321(7273), 2000, pp. 1397-1399
Authors:
Midgley, RSJ
Kerr, DJ
Citation: Rsj. Midgley et Dj. Kerr, ABC of colorectal cancer - Adjuvant therapy, BR MED J, 321(7270), 2000, pp. 1208
Authors:
Djeha, AH
Hulme, A
Dexter, MT
Mountain, A
Young, LS
Searle, PF
Kerr, DJ
Wrighton, CJ
Citation: Ah. Djeha et al., Expression of Escherichia coli B nitroreductase in established human tumorxenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954, CANC GENE T, 7(5), 2000, pp. 721-731
Authors:
Ferry, DR
Deakin, M
Baddeley, J
Daryanani, S
Bramhall, S
Anderson, DA
Wakelam, MJO
Doran, J
Pemberton, G
Young, AM
Buckels, J
Kerr, DJ
Citation: Dr. Ferry et al., A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints, ANN ONCOL, 11(9), 2000, pp. 1165-1170
Authors:
Kerr, DJ
Gray, R
McConkey, C
Barnwell, J
Citation: Dj. Kerr et al., Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: Non-randomised comparison of weekly versus four-weekly schedules - less pain, same gain, ANN ONCOL, 11(8), 2000, pp. 947-955
Authors:
Stone, P
Richardson, A
Ream, E
Smith, AG
Kerr, DJ
Kearney, N
Citation: P. Stone et al., Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey, ANN ONCOL, 11(8), 2000, pp. 971-975
Authors:
Kerr, DJ
Citation: Dj. Kerr, A national cancer plan for the UK, ANN ONCOL, 11(12), 2000, pp. 1511-1512
Authors:
Kerr, DJ
Midgley, RJ
McArdle, CS
Citation: Dj. Kerr et al., Hepatic arterial chemotherapy: Still on trial, J CL ONCOL, 18(8), 2000, pp. 1806-1807
Authors:
Nicum, S
Midgley, R
Kerr, DJ
Citation: S. Nicum et al., Chemotherapy for colorectal cancer, J ROY S MED, 93(8), 2000, pp. 416-419
Authors:
Young, A
Kerr, DJ
Citation: A. Young et Dj. Kerr, Genetic and immunological therapy for cancer, J ROY S MED, 93(1), 2000, pp. 10-14